EP. 1: <i>Pseudomonas</i> Infections in the ICU: Who's Susceptible?
Watch
EP. 2: <i>Pseudomonas</i> Infections: Matching Causes and Prevention
EP. 3: <i>Pseudomonas</i> Infections in the ICU Versus on the Floor
EP. 4: <i>Pseudomonas</i> Infections: Nuancing the Use of Antibiotics
EP. 5: Fighting <i>Pseudomonas</i>: Impact On Patient Prognosis & Approaches to Combat Infection
EP. 6: Classes and Agents Available to Treat <i>Pseudomonas</i> Infections
EP. 7: <i>Pseudomonas</i> Infections Continue to Acquire Resistance, Complicating Treatment
EP. 8: Exploring Cephalosporin/β-Lactamase Inhibitor Combinations for Treatment of <i>Pseudomonas</i>
EP. 9: Exploring Appropriate Treatment Protocols for <i>Pseudomonas</i> Infections
EP. 10: Core Challenges in <i>Pseudomonas</i> Treatment Protocol
EP. 11: <i>Pseudomonas</i> Infections: Optimizing Diagnostic Strategies
EP. 12: Pseudomonas Infections: Selecting Upfront Antibiotics
EP. 13: <i>Pseudomonas</i> Infections: Secondary Approach to Treatment
EP. 14: Treating <i>Pseudomonas</i> Infections With Zerbaxa or Avycaz
EP. 15: Zerbaxa and Avycaz: Considerations for Treatment
EP. 16: The Future Treatment of Pseudomonas Infections
